D
Duo Li
Researcher at Qingdao University
Publications - 359
Citations - 11451
Duo Li is an academic researcher from Qingdao University. The author has contributed to research in topics: Polyunsaturated fatty acid & Docosahexaenoic acid. The author has an hindex of 48, co-authored 329 publications receiving 9060 citations. Previous affiliations of Duo Li include Hangzhou University & Ruhr University Bochum.
Papers
More filters
Journal ArticleDOI
Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.
TL;DR: Data indicate that a decrease in cyclin B/Cdc2 complex activity mediated G2/M phase arrest induced by myricetin in HepG2 cells provides insight into the potential applications of myricETin in the treatment of hepatocellular carcinoma.
Journal ArticleDOI
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
Zu-Quan Zou,Xiaohong Zhang,Feng Wang,Shen Qijun,Jin Xu,Zhang Lina,Wen-Hua Xing,Ren-Jie Zhuo,Duo Li +8 more
TL;DR: The results suggest that multitargeted intervention is the most effective tumor therapy, and the cooperative blockade of PI3Kalpha and mTOR with PI-103 shows promise for treating gefitinib-resistant NSCLC.
Journal ArticleDOI
Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials
TL;DR: The present meta-analysis provides substantial evidence that n-3 PUFA supplementation, especially DHA, has a favorable effect in treatment of NAFLD.
Journal ArticleDOI
Health effects of vitamin and mineral supplements.
TL;DR: Growing numbers of healthy people are taking dietary supplements but there is little evidence that they protect against non-communicable diseases, say Fang Fang Zhang and colleagues.
Journal ArticleDOI
Incorporation and metabolism of punicic acid in healthy young humans.
TL;DR: It is suggested that PA can be effectively incorporated into human plasma and RBCM, and is also associated with the increasing proportion of cis9,trans11-18:2 in humans, presumably as a result of metabolism by a saturation reaction.